These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of vasoactive peptides in blood pressure control. Brunner HR J Hum Hypertens; 1993 Aug; 7(4):375-81. PubMed ID: 8410929 [No Abstract] [Full Text] [Related]
25. [New stage in the study of the central effects on digestive system functions]. Klimov PK Fiziol Zh SSSR Im I M Sechenova; 1982 May; 68(5):621-6. PubMed ID: 6284557 [TBL] [Abstract][Full Text] [Related]
26. Modulation of adrenal chromaffin cell intracellular calcium by angiotensin, bradykinin and endothelin. Printz MP; Rasmussen K Endocrinol Exp; 1990 Mar; 24(1-2):55-61. PubMed ID: 2193794 [TBL] [Abstract][Full Text] [Related]
27. Effect of intracerebroventricular bradykinin and related peptides on rabbit operant behavior. Melo JC; Graeff FG J Pharmacol Exp Ther; 1975 Apr; 193(1):1-10. PubMed ID: 1094106 [TBL] [Abstract][Full Text] [Related]
28. Actions of gangliosides on neural cells and possible interactions with trophic factors in CNS repair. Varon S Clin Neuropharmacol; 1986; 9 Suppl 4():341-3. PubMed ID: 3567948 [No Abstract] [Full Text] [Related]
29. Modulation of sympathetic control by ACE inhibitors. Dominiak P Eur Heart J; 1993 Nov; 14 Suppl I():169-72. PubMed ID: 8293770 [TBL] [Abstract][Full Text] [Related]
30. Central sympathoexcitatory actions of angiotensin II: role of type 1 angiotensin II receptors. DiBona GF J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S90-4. PubMed ID: 9892146 [TBL] [Abstract][Full Text] [Related]
31. [Polypeptides and antagonists]. Regoli D Sem Hop; 1984 Mar; 60(14):987-1002. PubMed ID: 6202006 [TBL] [Abstract][Full Text] [Related]
32. The peptide molecular links between the central nervous and the immune systems. Siemion IZ; Kluczyk A; Cebrat M Amino Acids; 2005 Nov; 29(3):161-76. PubMed ID: 16059661 [TBL] [Abstract][Full Text] [Related]
33. [Effect of kinins on the central nervous system (review)]. Posokhov VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(5):774-8. PubMed ID: 3927638 [No Abstract] [Full Text] [Related]
34. [Levels of regulation of immune homeostasis]. Korneva EA Fiziol Cheloveka; 1984; 10(2):193-201. PubMed ID: 6152427 [No Abstract] [Full Text] [Related]
35. Regulation of levels of guanosine cyclic 3',5'-monophosphate in the central nervous system: effects of depolarizing agents. Ferrendelli JA; Kinscherf DA; Chang MM Mol Pharmacol; 1973 Jul; 9(4):445-54. PubMed ID: 4353550 [No Abstract] [Full Text] [Related]
36. [Adrenomedullin in the central nervous system]. Ueta Y Nihon Rinsho; 2004 Sep; 62 Suppl 9():246-51. PubMed ID: 15506379 [No Abstract] [Full Text] [Related]
37. [Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors]. Adam A; Blais C; Loute G Nephrologie; 2000; 21(4):163-72. PubMed ID: 10976431 [TBL] [Abstract][Full Text] [Related]
38. Role of cyclic nucleotides in the nervous system. Vapaatalo H Med Biol; 1974 Jun; 52(3):200-7. PubMed ID: 4370587 [No Abstract] [Full Text] [Related]
39. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products]. Dyr JE; Cajthamlová H; Suttnar J Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231 [TBL] [Abstract][Full Text] [Related]
40. Activation of the central vasopressin system: a potential factor in the etiology of hypertension. Gruber KA; Eskridge SL; Callahan MF Klin Wochenschr; 1987; 65 Suppl 8():82-6. PubMed ID: 3599806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]